W. Michael Flanagan insider trades

Open-market stock purchases and sales by W. Michael Flanagan, Unknown at Atrium Therapeutics, Inc, from SEC Form 4 filings since Jan 21, 2021.

Recent trades

DateStockTradeValue
Feb 27, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$669K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$946K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$2.2M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$473K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$894K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Jan 21, 2026RNA Avidity Biosciences, IncSold$288K
Jan 21, 2026RNA Avidity Biosciences, IncSold$185K
Jan 7, 2026RNA Avidity Biosciences, IncSold$171K
Dec 17, 2025RNA Avidity Biosciences, IncBought (not open market)—
Dec 17, 2025RNA Avidity Biosciences, IncSold (not open market)$984K

Companies traded

  • RNA Atrium Therapeutics, Inc: 19 sales, last Feb 27, 2026
  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026

Get free alerts when W. Michael Flanagan files a new trade →